Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

The S&P 500 won't pull back next year as the market enters the third year of a cyclical bull run, Brian Belski said.

Fiserv (NYSE:FI – Get Free Report) had its price objective upped by analysts at BMO Capital Markets from $222.00 to $232.00 ...

Brian Belski, chief investment strategist at BMO Capital Markets, joins 'Halftime Report' to lay out his case for his firm's ...

TJX Cos raised its annual profit forecast on Wednesday, benefiting from lower costs and strong demand from cash-strapped ...

Goldman Sachs sees the S&P 500 gaining 11% over the next year as stock market gains continue to broaden out from a few large ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.50% of ...

Yields on U.S. government debt were broadly moving higher Wednesday morning as traders focused on the prospects for U.S. economic growth. The 10-year yield rose to roughly 4.43% in New York morning ...

Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...

Donald Trump’s presidential win is likely to be gold positive in the medium term, according to John Reade, chief market ...

Salesforce (NYSE:CRM – Free Report) had its price target upped by BMO Capital Markets from $305.00 to $385.00 in a research ...